Drawing for TRIAL

USPTO serial 79357620

TRIAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
HINES, REGINA C
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TRIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Software; software and applications for mobile devices; downloadable software applications; specialized software; collaborative software; data communication software; file sharing software; document management software; software for management of data and files and for databases; process control software; data processing software; product lifecycle management software; industrial process management software; software for production process monitoring, analysis, control and operation; software for verification of the regulatory compliance of goods; software for monitoring the regulatory compliance of clinical trials; software for quality control in the field of medical devices and the pharmaceutical industry; software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trialsACTIVE
038Providing access to and rental of access time to a database; providing access to data or documents in electronic format on centralized files for remote consultation; providing access to platforms and portals on the Internet; electronic transmission of messages, data and documentsACTIVE
042Hosting services and software as a service and rental of software; development, programming and implementation of software; development, programming and implementation of data processing software; development, programming and implementation of software for checking the regulatory compliance of goods; development, programming and implementation of software for quality control of goods and clinical studies; accreditation services (certification of skills and quality) in the field of medical devices and the pharmaceutical industry; certification (quality control); quality control consultation; analysis and assessment of product design in the field of medical devices and the pharmaceutical industry; qualitative assessment of the performance of pharmaceuticals, medical products and medical devices; providing information on product development; preliminary assessment services in the field of new pharmaceuticals, medical products and medical devices; pharmaceutical research and development consultation services; consultation services on product development in the field of medical devices and the pharmaceutical industry; providing information on the results of clinical trials for pharmaceuticals, medical products and medical devices; design and development of medical technologies; design and development of analytical methods and tests; research and development services in the field of medical devices and pharmaceuticals; scientific and technological design services; conducting of scientific feasibility studies; carrying out technical feasibility studies; feasibility studies with respect to product design; feasibility studies with respect to analysis of materials; feasibility studies with respect to clinical trials; planning and conducting preclinical and clinical studies; providing medical and scientific research information of pharmaceuticals and clinical trials; conducting clinical trials for third parties (scientific research); conducting clinical trials for pharmaceuticals, medical products and medical apparatus; conducting of clinical studies; scientific research; medical research; pharmaceutical research and development; study of technical projects in the field of medical devices and the pharmaceutical industry; assessment of chemical information in relation to risks; assessment of toxicological information in relation to risks; risk assessment in the field of medical devices and the pharmaceutical industry; scientific assessment of risks; analytical laboratory services; laboratory research services relating to pharmaceuticals, medical devices and medical products; scientific laboratory services; advisory services with respect to laboratory tests; scientific diagnostic test servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 15, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 21, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 21, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 11, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 15, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 20, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 20, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 29, 2023RFNTREFUSAL PROCESSED BY IB
Aug 7, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 7, 2023RFRRREFUSAL PROCESSED BY MPU
Jul 1, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 1, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 30, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2023DOCKASSIGNED TO EXAMINER
Dec 23, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 19, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance